Neuroplasticity; the mechanisms and implications for treatment of neurological and psychiatric disorders

被引:0
|
作者
Lea, Hannah [1 ]
机构
[1] CALTECH, Pasadena, CA 91125 USA
关键词
Neuroplasticity (N); treatment of neurological (TN); psychiatric disorders (PD);
D O I
10.15761/0101-60830000000440
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
The primary goal of this research project is to measure neuroplasticity, as well as the processes and implications for the treatment of neurological and psychiatric illnesses. Because this research study is focused on secondary forms, the research is based on theoretical ideas and some numerical data analysis. E-views software was utilized to measure the research study and create useful findings, which comprised descriptive statistics, unit root test analysis, cointegration test analysis, and the ganger test, as well as some graphical test analysis connected to the indicators. The general conclusion discovered that there is a strong and direct relationship between neuroplasticity and the treatment of neurological and mental disorders. Research indicated that this topic still needs additional research. Researcher suggest that the future revisions of both instructions establish a formal mechanism for studying each diagnostic criteria set for potential conceptual mistakes. That could result in wrong positives in order to prevent psychiatric diagnosis from being overwhelmed by clear defects that are apparent to the press and the general public but proceed ignored by professionals.
引用
收藏
页码:1 / 9
页数:9
相关论文
共 50 条
  • [1] Psychiatric Implications of Neurological Disorders
    Irfan, Muna
    [J]. PSYCHIATRIC ANNALS, 2017, 47 (05) : 224 - 225
  • [2] NEUROPLASTICITY IN SCHIZOPHRENIA: MECHANISMS AND TREATMENT IMPLICATIONS
    Keshavan, Matcheri S.
    [J]. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2013, 47 (S1): : 1 - 1
  • [3] SUMOylation in Neuroplasticity and Neurological Disorders
    Feligioni, Marco
    Mattson, Mark P.
    Nistico, Robert
    [J]. NEUROMOLECULAR MEDICINE, 2013, 15 (04) : 637 - 638
  • [4] Mitochondria in Neuroplasticity and Neurological Disorders
    Mattson, Mark P.
    Gleichmann, Marc
    Cheng, Aiwu
    [J]. NEURON, 2008, 60 (05) : 748 - 766
  • [5] SUMOylation in Neuroplasticity and Neurological Disorders
    Marco Feligioni
    Mark P. Mattson
    Robert Nisticò
    [J]. NeuroMolecular Medicine, 2013, 15 : 637 - 638
  • [6] Apolipoproteins in the brain: implications for neurological and psychiatric disorders
    Elliott, David A.
    Weickert, Cyndi Shannon
    Garner, Brett
    [J]. CLINICAL LIPIDOLOGY, 2010, 5 (04) : 555 - 573
  • [7] Mechanisms of neurotoxicity and implications for neurological disorders
    Ceccatelli, S.
    [J]. JOURNAL OF INTERNAL MEDICINE, 2013, 273 (05) : 426 - 428
  • [8] Vitamin D binding protein in psychiatric and neurological disorders: Implications for diagnosis and treatment
    Li, Ling
    Han, Bing
    Kong, Yan
    Zhang, Gaojia
    Zhang, Zhijun
    [J]. GENES & DISEASES, 2024, 11 (05)
  • [9] Transcranial direct current stimulation and neuroplasticity genes: implications for psychiatric disorders
    Chhabra, Harleen
    Shivakumar, Venkataram
    Agarwal, Sri Mahavir
    Bose, Anushree
    Venugopal, Deepthi
    Rajasekaran, Ashwini
    Subbanna, Manjula
    Kalmady, Sunil V.
    Narayanaswamy, Janardhanan C.
    Debnath, Monojit
    Venkatasubramanian, Ganesan
    [J]. ACTA NEUROPSYCHIATRICA, 2016, 28 (01): : 1 - 10
  • [10] Excitotoxicity in the pathogenesis of neurological and psychiatric disorders: Therapeutic implications
    Olloquequi, Jordi
    Cornejo-Cordova, Elizabeth
    Verdaguer, Ester
    Soriano, Francesc X.
    Binvignat, Octavio
    Auladell, Carme
    Camins, Antoni
    [J]. JOURNAL OF PSYCHOPHARMACOLOGY, 2018, 32 (03) : 265 - 275